Notable Labs, a cancer drug testing startup, has named two industry veterans as part of its executive lineup: Hiroomi Tada, formerly from Incyte, as chief medical officer and Lloyd Mackenzie, previously of Aquinox Pharmaceuticals, as chief development officer. Notable is collaborating with the University of Kansas Cancer Center's Institute for Advancing Medical Innovation as it prepares to launch its first trial for its lead candidate ND-1000, a treatment for adult and pediatric patients with blood cancers.
Startup brings on 2 industry veterans as it preps for blood cancer trial
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.